The global AI in medical imaging market size is calculated at USD 1.67 billion in 2025 and is forecasted to reach around USD 14.46 billion by 2034, accelerating at a CAGR of 27.10% from 2025 to 2034. The North America AI in medical imaging market size surpassed USD 494.27 million in 2024 and is expanding at a CAGR of 27.50% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: AI in Medical Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. AI in Medical Imaging Market, by AI Technology
8.1.1. Deep Learning
8.1.1.1. Market Revenue and Forecast
8.1.2. Natural Language Processing (NLP)
8.1.2.1. Market Revenue and Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Forecast
9.1. AI in Medical Imaging Market, by Solution
9.1.1. Software Tools/ Platform
9.1.1.1. Market Revenue and Forecast
9.1.2. Services
9.1.2.1. Market Revenue and Forecast
9.1.3. Integration
9.1.3.1. Market Revenue and Forecast
9.1.4. Deployment
9.1.4.1. Market Revenue and Forecast
10.1. AI in Medical Imaging Market, by Modality
10.1.1. CT Scan
10.1.1.1. Market Revenue and Forecast
10.1.2. MRI
10.1.2.1. Market Revenue and Forecast
10.1.3. X-rays
10.1.3.1. Market Revenue and Forecast
10.1.4. Ultrasound Imaging
10.1.4.1. Market Revenue and Forecast
10.1.5. Nuclear Imaging
10.1.5.1. Market Revenue and Forecast
11.1. AI in Medical Imaging Market, by Application
11.1.1. Digital Pathology
11.1.1.1. Market Revenue and Forecast
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast
11.1.3. Cardiovascular
11.1.3.1. Market Revenue and Forecast
11.1.4. Neurology
11.1.4.1. Market Revenue and Forecast
11.1.5. Lung (Respiratory System)
11.1.5.1. Market Revenue and Forecast
11.1.6. Breast (Mammography)
11.1.6.1. Market Revenue and Forecast
11.1.7. Liver (GI)
11.1.7.1. Market Revenue and Forecast
11.1.8. Oral Diagnostics
11.1.8.1. Market Revenue and Forecast
11.1.9. Other
11.1.9.1. Market Revenue and Forecast
12.1. AI in Medical Imaging Market, by End Use
12.1.1. Hospital and Healthcare Providers
12.1.1.1. Market Revenue and Forecast
12.1.2. Patients
12.1.2.1. Market Revenue and Forecast
12.1.3. Pharmaceuticals and Biotechnology Companies
12.1.3.1. Market Revenue and Forecast
12.1.4. Healthcare Payers
12.1.4.1. Market Revenue and Forecast
12.1.5. Others
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by AI Technology
13.1.2. Market Revenue and Forecast, by Solution
13.1.3. Market Revenue and Forecast, by Modality
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End Use
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by AI Technology
13.1.6.2. Market Revenue and Forecast, by Solution
13.1.6.3. Market Revenue and Forecast, by Modality
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End Use
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by AI Technology
13.1.7.2. Market Revenue and Forecast, by Solution
13.1.7.3. Market Revenue and Forecast, by Modality
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End Use
13.2. Europe
13.2.1. Market Revenue and Forecast, by AI Technology
13.2.2. Market Revenue and Forecast, by Solution
13.2.3. Market Revenue and Forecast, by Modality
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End Use
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by AI Technology
13.2.6.2. Market Revenue and Forecast, by Solution
13.2.6.3. Market Revenue and Forecast, by Modality
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End Use
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by AI Technology
13.2.9.2. Market Revenue and Forecast, by Solution
13.2.9.3. Market Revenue and Forecast, by Modality
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End Use
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by AI Technology
13.2.12.2. Market Revenue and Forecast, by Solution
13.2.12.3. Market Revenue and Forecast, by Modality
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End Use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by AI Technology
13.2.14.2. Market Revenue and Forecast, by Solution
13.2.14.3. Market Revenue and Forecast, by Modality
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End Use
13.3. APAC
13.3.1. Market Revenue and Forecast, by AI Technology
13.3.2. Market Revenue and Forecast, by Solution
13.3.3. Market Revenue and Forecast, by Modality
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End Use
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by AI Technology
13.3.6.2. Market Revenue and Forecast, by Solution
13.3.6.3. Market Revenue and Forecast, by Modality
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End Use
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by AI Technology
13.3.8.2. Market Revenue and Forecast, by Solution
13.3.8.3. Market Revenue and Forecast, by Modality
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End Use
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by AI Technology
13.3.10.2. Market Revenue and Forecast, by Solution
13.3.10.3. Market Revenue and Forecast, by Modality
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End Use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by AI Technology
13.3.11.2. Market Revenue and Forecast, by Solution
13.3.11.3. Market Revenue and Forecast, by Modality
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End Use
13.4. MEA
13.4.1. Market Revenue and Forecast, by AI Technology
13.4.2. Market Revenue and Forecast, by Solution
13.4.3. Market Revenue and Forecast, by Modality
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End Use
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by AI Technology
13.4.6.2. Market Revenue and Forecast, by Solution
13.4.6.3. Market Revenue and Forecast, by Modality
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End Use
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by AI Technology
13.4.8.2. Market Revenue and Forecast, by Solution
13.4.8.3. Market Revenue and Forecast, by Modality
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End Use
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by AI Technology
13.4.10.2. Market Revenue and Forecast, by Solution
13.4.10.3. Market Revenue and Forecast, by Modality
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End Use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by AI Technology
13.4.11.2. Market Revenue and Forecast, by Solution
13.4.11.3. Market Revenue and Forecast, by Modality
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End Use
13.5. Latin America
13.5.1. Market Revenue and Forecast, by AI Technology
13.5.2. Market Revenue and Forecast, by Solution
13.5.3. Market Revenue and Forecast, by Modality
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End Use
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by AI Technology
13.5.6.2. Market Revenue and Forecast, by Solution
13.5.6.3. Market Revenue and Forecast, by Modality
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End Use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by AI Technology
13.5.8.2. Market Revenue and Forecast, by Solution
13.5.8.3. Market Revenue and Forecast, by Modality
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End Use
14.1. Agfa-Gevaert Group/Agfa HealthCare
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Arterys
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. AI
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. AZmed
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Butterfly Network
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Caption Health
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. CellmatiQ
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. dentalXrai
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Digital Diagnostics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. EchoNous
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client